US Patent 9908943 Single domain antibodies capable of modulating BACE activity
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+419 characters)
Article
Patent abstract
Described are single domain antibodies with a specificity for BACE1. More specifically, described are single variable-domain antibodies derived from camelids that bind to BACE1 and are capable of inhibiting the activity of BACE1. The antibodies can be used for research and medical applications. Specific applications include the use of BACE1-specific antibodies for the treatment of Alzheimer's disease.
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Bart De Strooper0
Els Marjaux0
Lujia Zhou0
Serge Muyldermans0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09908943 Single domain antibodies capable of modulating BACE activity US Patent 9908943 Single domain antibodies capable of modulating BACE activity
Infobox
Patent Number
099089430
Patent Number
99089430
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
099089430
Date of Patent
March 6, 2018
0Patent Application Number
140235860
Date Filed
September 11, 2013
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09908943 Single domain antibodies capable of modulating BACE activity
Infobox
Is a
Patent jurisdiction
Patent number
09908943
Date of patent
March 6, 2018
Patent application number
14023586
Date Filed
September 11, 2013
Patent primary examiner
Find more entities like US Patent 9908943 Single domain antibodies capable of modulating BACE activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
